Hemogenyx Pharmaceuticals (HEMO)

Sector:

Pharma and Biotech

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

2.53p
   
  • Change Today:
    -0.20p
  • 52 Week High: 4.25
  • 52 Week Low: 2.50
  • Currency: UK Pounds
  • Shares Issued: 356.04m
  • Volume: 1,930,056
  • Market Cap: 8.99m
  • RiskGrade: 343
2015-12-23 - Suspension of Listing

1 Day Chart (21-02-2019)

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn n/a n/a
ROCE n/a  
Latest F'cast
P/E 1.3 n/a
PEG n/a n/a
Pr/Revenue n/a n/a
Pr/Book 4.2  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

HEMO Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
28-Feb-15 n/a (0.01) (0.40)p n/a n/a n/a n/a 0.0%
31-Dec-15 n/a 0.08 0.60p 6.3 n/a n/a n/a 0.0%
31-Dec-16 n/a (0.47) (0.70)p n/a n/a n/a n/a 0.0%
31-Dec-17 n/a (2.36) 1.90p 1.3 n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

HEMO Company Announcements

Presentation at Cancer Immunotherapy Conference 30-Jan-2019 07:00 RNS
Operations Update 07-Jan-2019 07:00 RNS
Directorate Change 20-Dec-2018 07:00 RNS

Latest HEMO Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

HEMO Market Data

Currency UK Pounds
Share Price 2.53p
Change Today -0.20p
% Change -7.34 %
52 Week High 4.25
52 Week Low 2.50
Volume 1,930,056
Shares Issued 356.04m
Market Cap 8.99m
RiskGrade 343

HEMO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
24.21% above the market average24.21% above the market average24.21% above the market average24.21% above the market average24.21% above the market average
6.90% above the sector average6.90% above the sector average6.90% above the sector average6.90% above the sector average6.90% above the sector average
Value
24.21% above the market average24.21% above the market average24.21% above the market average24.21% above the market average24.21% above the market average
6.90% above the sector average6.90% above the sector average6.90% above the sector average6.90% above the sector average6.90% above the sector average
Income Not Available
Growth Not Available

HEMO Dividends

No dividends found

Trades for 21-Feb-2019

Time Volume / Share Price
14:18 2,000,000 @ 2.47p
15:12 500,000 @ 2.50p
15:05 30,000 @ 2.55p
14:38 100,000 @ 2.55p
14:34 89,570 @ 2.55p

HEMO Key Personnel

CEO Vladislav Sandler Ph.D.

Top of Page